Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$86.72 USD
-0.64 (-0.73%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $86.73 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$86.72 USD
-0.64 (-0.73%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $86.73 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Zacks News
Previewing the Q1 Earnings Season
by Sheraz Mian
Is the earnings picture really as bad as some are suggesting it is?
Q2 Earnings Season in Rearview Mirror
by Sheraz Mian
Q2's earnings growth strength has been broad-based and driven by top-line gains.
Record Earnings & Stronger Growth in Q2
by Sheraz Mian
The 2014 Q2 earnings season is moving towards the finish line.
Strong Earnings Season Winding Down
by Sheraz Mian
It's been tough for the retailers in recent quarters and Q2 is no different.
What is Your Stock's Earnings Yield?
by Kevin Matras
Kevin Matras talks about a stock's Earnings Yield and how to use it. Highlighted stocks include GILD, LYB, MGA, RFMD and UAL.
Q3 Earnings Estimates Not Falling As Much
by Sheraz Mian
The reduced negative revisions rate at this stage in the reporting cycle is the most notable positive element of this earnings season.
Can the Earnings Rebound be Sustained?
by Sheraz Mian
The 2014 Q2 earnings season is presenting a much improved picture.
Closing the Books on Q1 Earnings Season
by Sheraz Mian
What we saw this earnings season was anemic growth and continuation of the negative guidance.
Another Weak Earnings Season Coming to an End
by Sheraz Mian
What we saw this earnings season was anemic growth and continuation of the negative guidance.
Q1 Earnings Season Coming to an End
by Sheraz Mian
What we saw this earnings season was anemic growth and continuation of the negative guidance.
Q1 Earnings Season in Final Stretch
by Sheraz Mian
Earnings growth has been hard to come by for some time.
Q2 Earnings Estimates Coming Down
by Sheraz Mian
Earnings growth has been hard to come by for some time.
An Improving, But Still Weak Earnings Picture
by Sheraz Mian
There is still plenty that is disappointing about the Q1 earnings.